Rhomboid Intercostal and Subserratus Plane Block vs Erector Spinae Plane Block in Video-Assisted Thoracoscopic Surgery
Launched by BURSA CITY HOSPITAL · Jun 4, 2025
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods of pain relief for patients undergoing a type of surgery called video-assisted thoracoscopic surgery (VATS). The researchers want to compare the effectiveness of the rhomboid intercostal subserratus plane block and the erector spinae plane block. Both of these are regional anesthesia techniques that help manage pain after surgery, but they may affect breathing differently. The trial aims to see which method works better for patients' pain control and respiratory function following the surgery.
To participate in this study, patients should be between the ages of 18 and 80 and scheduled for elective VATS surgery. They should also be in good health according to a standard assessment by their doctor. However, individuals with certain conditions, such as severe allergies to local anesthetics or significant health issues affecting their lungs, will not be eligible. If you join the trial, you can expect to receive one of the two pain relief methods and be monitored for how well it helps with pain and breathing after your surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who will undergo VATS
- • Who agrees to participate
- • American Society of Anesthesiologists (ASA) physical status I, II, and III
- • Elective surgery
- • Age between 18 and 80 years
- Exclusion Criteria:
- • Local anesthetic allergy
- • Who disagrees to participate
- • ASA physical status IV and V
- • Emergency surgery
- • Hemorrhagic disease
- • Thoracic vertebrae deformity
- • Thoracic vertebrae surgery
About Bursa City Hospital
Bursa City Hospital is a premier healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a robust infrastructure, the hospital fosters collaboration between healthcare professionals and researchers to explore new therapies and treatment modalities. By participating in diverse clinical studies, Bursa City Hospital aims to contribute to the global medical community while ensuring the highest standards of safety and ethical practices in all research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bursa, Nilufer, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported